Budget 2026: Government announces ₹10,000cr push for biopharma sector
The government announced Biopharma SHAKTI—a ₹10,000 crore, five-year push to make India a global biopharma leader.
This means three new NIPERs (National Institutes of Pharmaceutical Education and Research), upgrades for seven more, and a big focus on research and drug development.
Biopharma SHAKTI isn't just about labs--it's about real impact
Biopharma SHAKTI isn't just about labs—it's about real impact. Over 1,000 clinical trial sites are coming up, plus better drug safety checks.
The plan tackles major health issues like diabetes and cancer by boosting homegrown medicines.
The Budget also proposes adding 100,000 allied health professionals over the next five years, and supporting five Regional Medical Hubs; these measures could open up jobs and even put India on the map for medical tourism.
If you're into science, healthcare careers, or just want better healthcare access—this is big news.